Table 1 Patient demographics and clinical features of the control subjects and patients with inactive and active stages of Graves’ orbitopathy
Control (n = 25) | Inactive stage (n = 27) | Active stage (n = 35) | P value | |
|---|---|---|---|---|
Sex (M/F) | 9/16 | 7/20 | 13/22 | 0.674 |
Mean age (years) | 38.56 ± 11.78 | 36.56 ± 13.75 | 41.48 ± 14.87 | 0.153 |
Visual acuity (LogMAR) | 0.03 ± 0.02 | 0.04 ± 0.02 | 0.10 ± 0.14 | 0.238 |
Proptosis (mm) | 16.12 ± 4.83 | 18.11 ± 3.38 | 17.54 ± 5.29 | 0.513 |
Palpebral fissure width (mm) | 12.28 ± 2.54 | 11.26 ± 3.38 | 12.49 ± 3.74 | 0.911 |
Clinical activity score | 1.33 ± 0.62 | 4.34 ± 1.30 | 0.001 | |
EOM enlargement in orbital CT | 10 (37.0%) | 19 (54.3%) | 0.035 | |
Thyroid hormone state | ||||
Hyperthyroid state | 16 (59.3%) | 20 (57.1%) | 0.781 | |
Euthyroid state | 10 (37.0%) | 13 (40.0%) | 0.684 | |
Hypothyroid state | 1 (3.7%) | 2 (5.7%) | 0.305 | |